Consilium MedicumConsilium Medicum2075-17532542-2170Consilium Medicum93002Research ArticleKombinirovannaya terapiya akarbozoy s metforminom: uspeshnyy kontrol' glikemii i preduprezhdenie istoshcheniya insulyarnogo apparataMkrtumyanA. M-151220091112252828122021Copyright © 2009, Consilium Medicum2009[Chiasson J.L., Gomis R, Hanefeld M et al. The Stop - NIDDM Trial. Diabetes Care 1998; 10 (21): 1720–5.][National Diabetes Data Group Classification and diagnosis of diabetes Mellitus and other categories of glucose Intolerance. Diabetes 1979; 28: 1039–57.][The Expert Committee on the Diagnosis Report of the Expert Committee on the and Classification of Diabetes Mellitus. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183–97.][Little R.R., England J.D., Wiedmeyer H.M. Relationship of glycosylated hemoglobin et al. to oral glucose tolerance: implications for diabetes screening. Diabetes 1988; 37: 60–4.][Fuller J.H., Shipley M.J., Rose G et al. Coronary - heart disease risk and impiared glucose tolerance: the Whitehall Study, Lancet 1980; 1373–6.][Gerich J.E. Metabolic abnormalities in impiared glucose tolerance. Metabolism Сlin and Exp 1997; 46 (12): 40–3.][Harris M. Impiared glucose tolerance - Prevalence and conversion to NIDDM. Diabet Med 1996; 13: S9–S11.][Gray A.M. Оценка показателя стоимость - эффект при лечении больных сахарным диабетом 2 типа. Медикография. 1999; 21 (4): 15–9.][ADA, American Diabetes Association. Economic consequences of diabetes mellitus in the US in 1997. Diabetes Care 1998; 21: 296–309.][De Fronzo R.A. Med Clin N Am 2004; 88: 787–835.][Hollander P.A., Elbein S.C. Role of orlistat in the treatment of obese Hirsch I.B., et al. patients with type 2 diabetes. Diabetes Care 1988; 1288–94.][Keina. nen - Kiukaanniemi S. Tuomilehto Type 2 diabetes can be prevented by J, Lindstro.m J et al. lifestyle intervention: the results from Finnish Diabetes Prevention Study. «Diabetes in the new millenium», 4th International coference St Vincent Declaration Primary Care Diabetes Group, Prague, 2000; Oct. 13–14: p. 21.][Chiasson J.L. et al. The stop-NIDDM trial. An international study on the efficacy of an a - glucosidase inhibitor to prevent type 2 diabetes in a population with IGT. Diabetes Care 1998; 21: 1720–5.][Yang Wenying, Lin Lixiang. The preventive effect of Acarbose and Qi Jinwu et al. Metfor min on the IGT population from becoming dia betes mellitus: a 3 - year multicentral prospective study. Clin J Endocrinol 2001; 3: 1–7.]